DGAM
TEVA icon

Desjardins Global Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Desjardins Global Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$84.8K Buy
8,123
+1,070
+15% +$9.99K 0.01% 487
2023
Q3 		$71.9K Buy
7,053
+234
+3% +$2.18K 0.01% 504
2023
Q2 		$51.3K Hold
6,819
– – 0.01% 536
2023
Q1 		$60K Buy
+6,819
New +$67.4K 0.01% 510

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Desjardins Global Asset Management's TEVA Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 15% in Q4 2023, buying an estimated $9.99K and bringing the position to 8,123 shares worth $84.8K. The position accounts for 0.01% of the portfolio, ranked #487.

Desjardins Global Asset Management first reported a position in TEVA in Q1 2023 and has held it in 4 quarters since. 448 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Desjardins Global Asset Management held 8,123 shares of Teva Pharmaceutical Industries Limited worth $84.8K as of Q4 2023.
  • Desjardins Global Asset Management bought 1,070 Teva Pharmaceutical Industries Limited shares in Q4 2023, an estimated $9.99K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #487 holding.
  • Desjardins Global Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2023 and has held it in 4 quarters since.
  • 448 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.